AI in Antithrombotic Drug Development: Transforming the Future of the Antithrombotic Drugs Market The integration of artificial intelligence (AI) into pharmaceutical research is revolutionizing modern medicine, particularly in cardiovascular therapeutics. One of the most promising areas of impact is antithrombotic therapy, where AI is accelerating discovery, improving drug safety, and...

Idiopathic thrombocytopenic purpura (ITP) is a rare autoimmune disorder characterized by low platelet counts, leading to an increased risk of bleeding and bruising. Advances in diagnosis and treatment have significantly improved patient management, creating new opportunities for pharmaceutical manufacturers and healthcare providers. The Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics...